Clinical Study Available to Treat Alzheimer’s Disease, Dementia, Traumatic Brain Injury and Parkinson’s Disease
—an IRB approved clinical study
Listed on clinicaltrials.gov (NCT06147999) -click here.
An opportunity for patients with brain-related disorders, such as Alzheimer’s disease, Dementia, Traumatic Brain Injury, and Parkinson’s disease, to improve quality of life: First Institute of All Medicines, a non-profit organization, is conducting a kind clinical study. This is a triple blinded, placebo-controlled, two-group randomized clinical study to confirm that Biophoton Generators can help to recover brain and body functions. This is an IRB-approved clinical study.
LOCATION: TESLA WELLNESS HOTEL & MEDBED CENTER
World’s First BioEnergy Wellness Hotel 139 Pittsburgh Road Butler, PA 16001 Telephone: 724-431-0033
Medical research staff of First Institute of All Medicines will be conducting this study using research facilities with the Biophoton-powered Tesla MedBed at the wellness center.
Our study participants and their caregiver guests will sleep on a Tesla MedBed, powered by biophoton generators. They will also enjoy our hotel amenities for the length of the study, including a climate-controlled biophoton-energized atmosphere, along with access to our energized pool and gym to exercise.
Participants: A total of 80 volunteers with clinically diagnosed Alzheimer’s disease, Dementia, Traumatic brain injury, and Parkinson’s disease.
Duration: Each study participant is to complete 4 or 6 weeks living in a hotel-like wellness center; this study is non-invasive. Simply sleep in a Tesla BioHealing MedBed powered with biophoton generators. This study is to start on November 15, 2023, and be completed for all participants on November 15, 2024.
Procedures: Sleep nightly in a bed with Tesla BioHealing Biophoton Generators underneath (or placebo) and complete life quality and cognitive capacity assessments. Brain disorder status information will be collected non-invasively by medical and clinical research professionals. The study participants initially placed in the Placebo group for 2 weeks will be switched to the Treatment group for 4 weeks after verifying the placebo effects and to be treated for 4 weeks, with a total of 6 weeks.
Qualification: There will be a qualification process to participate in this study. The study participant is to submit a doctor's diagnosis of Alzheimer’s disease, Dementia, Traumatic brain injury, or Parkinson’s disease. If you are interested in participating, please click the application link below, or use the contact information below to connect with the clinical research team. You are also welcome to reach out to us if you would like more specific information about participation.
Cost: Free to Use Biophoton Generators. Caregivers and qualified study participants are to stay at the MedBed Center Wellness Hotel free of charge for the length of the study. There is no direct cost to participate. However, the costs of travel and meals are not covered.
Apply today: The research team at First Institute of All Medicines (FIAM) looks forward to hearing from you! We encourage you to apply as soon as possible by following the secure application link below. Please also feel free to have a family member or caregiver assist with your application registration process by using our contact information..
CONTACT: Jessica Jackson, Clinical Study Coordinator First Institute of All Medicines 139 Pittsburgh Road, Butler, PA 16001. Direct Line: 302-922-2486 Email: Jessica.Jackson@FirstAllMed.org For general questions, please email: Info@FirstAllMed.org